Zucara Therapeutics Doses First Patients in Phase 1b Trial of ZT-01
TORONTO, ON – Zucara Therapeutics Inc., a diabetes life sciences company developing the first once-daily therapeutic to prevent insulin-induced hypoglycemia (low blood glucose levels), today announced that it has dosed… Read More




